Insulin resistance, which describes an impaired response to physiological concentrations of insulin, is strongly associated with obesity and type 2 diabetes, and contributes to cardiovascular risk(Reference Mokdad, Ford and Bowman1–Reference Ritchie and Connell3). Excess accumulation of saturated lipid, especially in skeletal muscle which is the major site of insulin-stimulated glucose uptake, is an important factor in the development of insulin resistance(Reference Baron, Bretchel and Wallace4–Reference McGarry6). Since insulin signalling to regulate glucose uptake in muscle is mediated largely through a pathway dependent upon phosphatidylinositol 3-kinase (PI3-kinase) and Akt phosphorylation, the effects of lipids on this pathway provide an important focus for the study of lipid-induced insulin resistance(Reference Roden, Price and Perseghin7–Reference Kruszynska, Worrall and Ofrecio9).
Insulin resistance caused by cellular lipid accumulation is mainly associated with SFA(Reference Lee, Pinnamaneni and Eo10). Palmitate, one of the most abundant SFA, representing about 30 % of the total NEFA in human plasma, has been shown to induce insulin resistance in cultured skeletal muscle cells and adipocytes(Reference Van Epps-Fung, Williford and Wells11, Reference Chavez and Summers12). By contrast, oleate, representing about 90 % of the monounsaturated NEFA and 30 % of the total NEFA in human plasma, has not been reported to cause significant insulin resistance. Recent studies have shown that combination of oleate with palmitate can reverse palmitate-induced alterations in insulin signal transduction(Reference Sabin, Stewart and Crowne13–Reference Coll, Eyre and Rodriguez-Calvo15). These studies also suggested that the oleate:palmitate ratio may influence the protective effect of oleate. However, these studies have not examined the effect of oleate on palmitate-induced insulin resistance at the level of glucose uptake.
The present study examines whether oleate protects against palmitate-induced insulin resistance at the level of glucose uptake in cultured rat L6 muscle cells. The study also investigates whether the PI3-kinase pathway is involved, and whether the morphology and viability of the cells are affected by palmitate and/or oleate.
Materials and methods
Materials
The L6 rat skeletal muscle cell line was obtained from the European Culture Collection (Porton Down, UK). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), an antibiotic and trypsin-EDTA were purchased from Cambrex (Verviers, Belgium). Sodium palmitate, sodium oleate, fatty acid-free bovine serum albumin (BSA), sodium pyruvate, PI3-kinase inhibitors (wortmannin and LY294002), trypan blue solution and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (Poole, UK). 2-Deoxy-d-[3H]glucose (555 GBq/mmol) was from Amersham International (Little Chalfont, Bucks, UK).
Cell culture
L6 myoblasts were grown in DMEM containing 5 % heat-inactivated FBS, 25 mm-d-glucose, 1 mm-sodium pyruvate, 1 mm-l-glutamine, penicillin (100 U/ml) and streptomycin (100 μg/ml) as described previously(Reference Bailey, Turner and Bates16). Cells were maintained at 37°C with humidified 95 % air and 5 % CO2. Experiments were undertaken in twenty-four-well plates seeded from preconfluent flasks with 5 × 104 cells in 1 ml. The cells were grown to 70–80 % confluence and the medium was changed to DMEM containing 0·5 % FBS for 24 h which induces rapid differentiation and fusion of these myoblasts into myotubes(Reference Bailey, Turner and Bates16).
Conjugation of fatty acids to bovine serum albumin
A stock solution of palmitate (200 mmol/l) or oleate (100 mmol/l) was prepared by dissolving sodium palmitate or sodium oleate into 70 % ethanol and 0·1 m-NaOH as described previously(Reference Zhang, Schwartz and Wang17). Fatty acids were then complexed with 5 % fatty acid-free BSA to a concentration of 5 mmol/l at 37°C, stirring for 4 h and adjusted to pH 7·4. After sterilising through a 0·2 μm filter, both solutions were stored at 4°C for no longer than 2 weeks. A control solution was prepared by mixing 70 % ethanol and 0·1 m-NaOH with 5 % BSA in the absence of fatty acids.
Incubation with fatty acids and phosphatidylinositol 3-kinase inhibitors
L6 myotubes were incubated with various concentrations of palmitate (50–300 μmol/l) or oleate (50–750 μmol/l) alone, and combinations of 300 μm-palmitate with 50–300 μm-oleate for 6 h. Palmitate (300 μmol/l) induces a time (0–6 h)-dependent reduction in insulin-stimulated glucose uptake which is maximal at 6 h and does not induce significant toxicity(Reference Gao18). Further experiments to investigate any involvement of the PI3-kinase pathway in the effects of fatty acids were undertaken with and without the PI3-kinase inhibitors wortmannin (10− 7 mol/l) for 6 h or LY294002 (25 μmol/l) for 1 h 10 min at 37°C. The presence of wortmannin at 10− 7 mol/l elicited a reduction of insulin-stimulated glucose uptake by L6 muscle cells over 6 h, from 140·5 (sem 4·8) to 105·5 (sem 3·2) % of non-insulin-stimulated glucose uptake (P < 0·001; n 8). Similarly, pre-incubation of L6 muscle cells with LY294002 for 10 min (25 μmol/l) reduced insulin-stimulated glucose uptake by L6 muscle cells from 150·1 (sem 11·5) to 93·3 (sem 4·6) % of non-insulin-stimulated glucose uptake (P < 0·001; n 9). Control cells received BSA and/or other vehicles as appropriate.
2-Deoxy-d-glucose uptake
2-Deoxy-d-glucose uptake was undertaken immediately after completion of the 6 h incubation with fatty acids in which insulin (10− 6 mol/l) had been added for the last 1 h. L6 myotubes were then washed with glucose-free Krebs–Ringer bicarbonate buffer at 22°C and incubated with 0·5 ml of this buffer supplemented with 0·1 mm-2-deoxy-d-glucose and 2-deoxy-d-[3H]glucose (3700 Bq/ml) for 10 min at 22°C. After washing cells three times with ice-cold Krebs–Ringer bicarbonate buffer, cells were lysed with 0·5 ml of 1 m-NaOH and radioactivity was counted in 5 ml Hi-safe 3 scintillant using a Packard 1900 TR liquid scintillation counter (Packard, Chicago, IL, USA). Uptake of 2-deoxy-d-glucose was expressed as the percentage compared with control (100 %), which was typically 5–8 pmol/105 cells per min for basal uptake of 2-deoxy-d-glucose in the present studies as reported previously(Reference Bailey and Turner19).
Cell viability assays
Trypan blue exclusion assay
For the trypan blue exclusion assay, L6 myotubes in twenty-four-well plates were gently washed with PBS, and trypsinised with 100 μl trypsin-EDTA for 2 min and neutralised with 100 μl DMEM with 10 % FBS. After mixing with 0·4 % trypan blue solution, the live cells were counted on a Neubauer haemocytometer (AO Scientific, Buffalo, NY, USA). Cell viability was expressed as percentage of live cells.
Caspase-3 activity assay
L6 myotubes in six-well plates were gently washed twice with ice-cold PBS. After application of lysis buffer (10 mm-2-amino-2-hydroxymethyl-propane-1,3-diol-HCl, pH 7·5, 130 mm-NaCl, 1 % TritonX-100, 10 mm-NaH2PO4, 0·4 mm-phenylmethanesulfonylfluoride, 0·2 mm-NaF, 0·2 mm-Na3VO4, leupeptin (0·3 mg/ml)) on ice for 30 min, cells were centrifuged at 10 000 g for 5 min. The supernatant fraction was collected and caspase-3 activity was measured using a fluorescent caspase-3 substrate II (7-amino-4-methylcoumarin, N-acetyl-l-aspartyl-l-glutamyl-l-valyl-l-aspartic acid amide; Ac-DEVD-AMC)(Reference Nicholson, Ali and Thornberry20) and protein content was measured by bicinchoninic acid protein assay(Reference Smith, Krohn and Hermanson21).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
For the MTT assay, the medium from treated and control L6 myotubes in twenty-four-well plates was removed and replaced with 0·5 ml fresh DMEM with 0·5 % FBS. Cells were then incubated with 100 μl MTT solution (10 mg/ml in PBS) for 4 h at 37°C. Lysis buffer (100 μl; 20 % SDS in 50 % dimethyl formamide, pH 4·7) was added to each well and the plates were incubated for a further 16 h at 37°C in a humidified 5 % CO2 air incubator. The absorbance was read at 570 nm using an MRX Microplate reader (Dynex Technologies Limited, Worthing, West Sussex, UK). Blank wells contained DMEM without cells.
Phase-contrast microscopy
To assess cell morphology, L6 myotubes were photographed under a phase-contrast microscope (Olympus, Southend-on-Sea, Essex, UK) at magnification × 20.
Statistical analysis
Data are expressed as mean values with their standard errors, and 2-deoxy-d-glucose uptake is expressed as percentage compared with control (100 %). Statistical analyses were performed by one-way ANOVA with Tukey–Kramer post hoc tests. P < 0·05 was considered significant.
Results
Effect of palmitate or oleate alone on glucose uptake
Initial experiments were conducted to characterise the effect of palmitate and oleate alone on basal and insulin-stimulated glucose uptake by L6 myotubes. Since palmitate was conjugated to BSA, the control and the oleate incubations were conducted with the same concentration of BSA. L6 myotubes were incubated with palmitate (50–300 μmol/l) or oleate (50–750 μmol/l) alone for 6 h. Both palmitate and oleate at the concentrations tested showed no significant effect on basal glucose uptake compared with controls (Fig. 1(a), (b)). When BSA-treated control cells were stimulated with 10− 6 m-insulin for 1 h, this produced a significant increase in glucose uptake by about 40–50 % which is a maximal insulin-induced effect for these cells over this time period (data not shown). However, when L6 myotubes were incubated with palmitate for 6 h, there was a concentration-dependent decrease in insulin-stimulated glucose uptake. Insulin-stimulated glucose uptake was almost completely prevented by exposure to 300 μm-palmitate (Fig. 1(a)). Therefore, this concentration of palmitate was chosen to induce insulin resistance in subsequent studies.
Effect of palmitate (a) and oleate (b) alone on basal (■) and insulin-stimulated (
) 2-deoxy-d-glucose (2-DG) uptake by L6 myotubes. L6 myotubes were incubated with bovine serum albumin (BSA) as control or BSA with palmitate (50–300 μmol/l) and oleate (50–750 μmol/l) alone for 6 h at 37°C. Insulin (10− 6 mol/l) was added for the last 1 h of incubation. Data are the means of three independent experiments performed in triplicate, with standard errors represented by vertical bars. Mean value was significantly different from that of the same treatment without insulin addition: ** P < 0·01, *** P < 0·001. Mean value was significantly different from that of the insulin-stimulated BSA-only-treated control (0 μm-palmitate): † P < 0·05, ††† P < 0·001.
Oleate alone caused a small concentration-dependent decrease in insulin-stimulated glucose uptake. The highest oleate concentration tested (750 μmol/l) did not completely prevent insulin-stimulated glucose uptake (Fig. 1(b)).
Oleate protects L6 cells from palmitate-induced insulin resistance
The effect of oleate on palmitate-induced insulin resistance was examined by co-incubating increasing concentrations of oleate (50, 150 and 300 μmol/l) with 300 μm-palmitate for 6 h with and without 10− 6 m-insulin stimulation for the last 1 h. Whereas 300 μm-palmitate alone abolished insulin-stimulated glucose uptake, co-incubation with oleate (50 μmol/l) partially restored (to 75 %) insulin-stimulated glucose uptake in the presence of 300 μm-palmitate, but co-incubation with 50 μm-BSA (control) did not exert any protective effect against the inhibition of insulin-stimulated glucose uptake by palmitate. The protective effect of oleate against palmitate-induced insulin resistance was not further affected by increasing the oleate concentration to 300 μmol/l (Fig. 2).
Effect of combinations of 300 μm-palmitate with various concentrations of oleate on basal (■) and insulin-stimulated () 2-deoxy-d-glucose (2-DG) uptake by L6 myotubes. L6 myotubes were incubated with 300 μm-palmitate and oleate (50, 150, 300 μmol/l) or 50 μm-bovine serum albumin as control for 6 h at 37°C. Insulin (10− 6 mol/l) was added for the last 1 h of incubation. Data are the means of three independent experiments performed in triplicate, with standard errors represented by vertical bars. *** Mean value was significantly different from that of the same treatment without insulin addition (P < 0·001).
Effects of fatty acids on L6 cell viability
To test whether fatty acids have adverse effects on L6 myotubes, membrane integrity was assessed by trypan blue exclusion, and mitochondrial-reducing capacity was measured by an MTT assay.
Cells incubated with 300 μm-oleate alone did not show any significant difference in membrane integrity compared with BSA controls. With 300 μm-palmitate, there was a slight reduction in membrane integrity compared with BSA controls (viability of 74 (sem 4) v. 88 (sem 3) %; P < 0·001). Co-incubating cells with 50–300 μm-oleate prevented the slight reduction in membrane integrity with 300 μm-palmitate (Fig. 3).
Effect of palmitate (Pa) and oleate (Oa) on viability measured as (a) membrane integrity by trypan blue exclusion and (b) caspase-3 activity in cell lysates. (a) L6 myotubes were incubated with 300 μm-Pa and 300 μm-Oa alone and combinations of 300 μm-Pa with various concentrations of Oa (50, 150, 300 μmol/l) or bovine serum albumin (BSA) for 6 h at 37°C. Viable cells were counted after trypsinisation. (b) L6 myotubes were incubated with BSA, 300 μm-Pa and 300 μm-Oa alone for 6 h at 37°C. Caspase-3 activity in lysates was measured as the release of coumarin fluorescence from the synthetic peptide 7-amino-4-methylcoumarin, N-acetyl-l-aspartyl-l-glutamyl-l-valyl-l-aspartic acid amide (Ac-DEVD-AMC). Data are the means of three independent experiments performed in triplicate, with standard errors represented by vertical bars. *** Mean value was significantly different from that of the Pa-only treatment (P < 0·001).
The overall pattern in mitochondrial-reducing activity was similar to that of membrane integrity. Palmitate (300 μmol/l) decreased mitochondrial-reducing activity by more than 50 % (P < 0·001), whereas the same concentration of oleate (300 μmol/l) caused a 25 % decrease in mitochondrial-reducing activity compared with BSA controls. Addition of 150 μm- and 300 μm-oleate with 300 μm-palmitate partially prevented the decrease in mitochondrial-reducing activity associated with palmitate (P < 0·001). A lower concentration of oleate (50 μmol/l) did not show a significant protective effect against the palmitate-induced decrease in mitochondrial-reducing activity (P>0·05) (Fig. 4).
Effect of palmitate (Pa) and oleate (Oa) on mitochondrial-reducing activity measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. L6 myotubes were incubated with 300 μm-Pa and 300 μm-Oa alone and combinations of 300 μm-Pa with various concentrations of Oa (50, 150, 300 μmol/l) or bovine serum albumin (BSA) for 6 h at 37°C. Data are the means of three independent experiments performed in triplicate, with standard errors represented by vertical bars. *** Mean value was significantly different from that of the Pa-only treatment (P < 0·001). ††† Mean value was significantly different from that of the BSA-only treatment (P < 0·001).
Oleate prevents the palmitate-induced alteration in L6 cell morphology
There was a distinct difference between the effects of palmitate and oleate alone on L6 myotube morphology. When L6 myotubes were incubated with 300 μm-palmitate, the muscle cells lost their spindle shape (Fig. 5(b)), whereas cells incubated with the same concentration of oleate maintained a similar shape to BSA controls (Fig. 5(c)). When 50 μm-oleate was co-incubated with 300 μm-palmitate, the spindle shape was retained (Fig. 5(d)). This protective effect of oleate was not further enhanced when the oleate concentration was raised to 150 and 300 μmol/l (Fig. 5(e), (f)). To exclude the possibility that BSA (a fatty acid carrier protein) could contribute to the protection by oleate, it was noted that the loss of spindle shape caused by palmitate was not prevented by co-incubating with increasing concentrations of BSA (Fig. 5(g), (h), (i)).
Effect of palmitate (Pa), oleate (Oa), combinations of palmitate with various concentrations of Oa or bovine serum albumin (BSA) on L6 myotube morphology. L6 myotubes were incubated with 300 μm-Pa and 300 μm-Oa alone and combinations of 300 μm-Pa with various concentrations of Oa (50, 150, 300 μmol/l) or BSA (8, 25, 50 μmol/l) for 6 h at 37°C. The cell cultures were photographed using an inverted phase-contrast light microscope at magnification × 20. (a) BSA control; (b) 300 μm-Pa; (c) 300 μm-Oa; (d) Pa +50 μm-Oa; (e) Pa +150 μm-Oa; (f) Pa +300 μm-Oa; (g) Pa +8 μm-BSA; (h) Pa +25 μm-BSA; (i) Pa +50 μm-BSA.
Phosphatidylinositol 3-kinase activity in palmitate- and oleate-treated L6 cells
To investigate the underlying mechanism of the protective effect of oleate against palmitate-induced insulin resistance in L6 myotubes, the involvement of PI3-kinase activation was examined by incubating L6 myotubes with two different types of PI3-kinase inhibitors: wortmannin which binds to the catalytic subunit (P110) and LY294002 which binds to the regulatory subunit (P85) of PI3-kinase(Reference Toker and Cantley22). Both wortmannin (10− 7 mol/l) and LY294002 (25 μmol/l) slightly reduced basal glucose uptake by 10 % (P < 0·05) and prevented insulin-stimulated glucose uptake by L6 myotubes (Fig. 6(a), (b)). The reduction in insulin-stimulated glucose uptake by 300 μm-palmitate was partially prevented by co-incubating with 50 μm-oleate as tested earlier (Fig. 2). With the addition of wortmannin (10− 7 mol/l) or LY294002 (25 μmol/l), the improvement in insulin-stimulated glucose uptake by 50 μm-oleate in 300 μm-palmitate-treated cells was significantly reduced (P < 0·001) (Fig. 6(a), (b)).
Effect of phosphatidylinositol 3-kinase inhibitors on basal (■) and insulin-stimulated () 2-deoxy-d-glucose (2-DG) uptake by L6 myotubes in the presence of palmitate (Pa) plus oleate (Oa). L6 myotubes were incubated with 300 μm-Pa and 50 μm-Oa with and without wortmannin (W) (10− 7 mol/l) (a) for 6 h or LY294002 (25 μmol/l) (b) for 10 min at 37°C. Insulin (10− 6 mol/l) was added for the last 1 h of incubation. Data are the means of three independent experiments performed in triplicate, with standard errors represented by vertical bars. Mean value was significantly different from that of the insulin-stimulated Pa+Oa-only-treatment: * P < 0·05, *** P < 0·001. ††† Mean value was significantly different from that of the insulin-stimulated Pa-, Oa- and inhibitor-absent treatment (P < 0·001).
Discussion
In the present study, the effect of oleate on palmitate-induced insulin resistance at the level of glucose transport was investigated in L6 myotubes. Treating L6 cells with 300 μm-palmitate for 6 h almost completely abolished insulin-stimulated glucose uptake. Oleate (up to 750 μmol/l) produced only a slight reduction in insulin-stimulated glucose uptake. However, addition of 50 μm-oleate reduced the inhibitory effect of 300 μm-palmitate on insulin-stimulated glucose uptake. This protective effect was not further increased with increasing concentrations of oleate up to 300 μmol/l but required the activity of PI3-kinase.
Fatty acid-induced insulin resistance has been extensively studied in vitro using skeletal muscle cells(Reference Sabin, Stewart and Crowne13, Reference Nicholson, Ali and Thornberry20). In L6 cells palmitate (300 μmol/l) reduced insulin-stimulated glucose uptake acutely (6 h), confirming previous studies with these cells(Reference Sinha, Perdomo and Brown23).
Two distinct fatty acid metabolites formed from oversupply of lipids to skeletal muscle have been implicated in the development of skeletal muscle insulin resistance: ceramide and diacylglycerol(Reference Boden, Chen and Ruiz24). Palmitate is an important precursor of de novo synthesis of ceramide(Reference Kolesnick and Krönke25), and ceramide strongly inhibits insulin action(Reference Hajduch, Balendran and Batty26, Reference Summers, Garza and Zhou27), mainly by disrupting activation of Akt (protein kinase B) and reducing translocation of GLUT into the cell membrane(Reference Schmitz-Peiffer, Craig and Biden28–Reference Powell, Turban and Gray30). Studies of lipid-induced insulin resistance in muscles of animals and human subjects support a role of diacylglycerol in the activation of the protein kinase Cθ–NF-κB pathway(Reference Itani, Ruderman and Schmieder31). This involves serine phosphorylation of insulin receptor substrate-1 and an associated reduction of PI3-kinase activity(Reference Griffin, Marcucci and Cline32).
Although oleate alone (up to 750 μmol/l) slightly reduced insulin-stimulated glucose uptake by L6 myotubes, only 50 μm-oleate was required to prevent 300 μm-palmitate-induced insulin resistance. This observation is consistent with a recently published study in which 100 μm-oleate reversed 500 μm-palmitate-induced insulin resistance in C2C12 myotubes; this effect involved altered phosphorylation of Akt(Reference Coll, Eyre and Rodriguez-Calvo15). Using the PI3-kinase inhibitors, wortmannin and LY294002, we have demonstrated that the effect of oleate to partially reverse palmitate-induced insulin resistance requires PI3-kinase activity, which is an insulin-signalling intermediate between insulin receptor substrate-1 and the 3-phosphoinositide-dependent kinase that regulates Akt. It is anticipated that reactivation of this pathway will restore GLUT-4 translocation and glucose transport(Reference Karlsson and Zierath33). It has been reported previously that long-term exposure to oleate can stimulate the activation of PI3-kinase in MDA-MB-231 cancer cells(Reference Hardy, Langelier and Prentki34). Since the present study involves only 6 h exposure to oleate, the effect of oleate on PI3-kinase is unlikely to be a direct effect on gene expression. Also, oleate alone did not increase insulin-stimulated glucose uptake.
It has been proposed that palmitate-induced insulin resistance could be mediated via protein kinase Cθ-induced serine-phosphorylation to suppress insulin receptor substrate-1, which then reduces PI3-kinase activity(Reference Griffin, Marcucci and Cline32, Reference Kim, Fillmore and Sunshine35). Activation of protein kinase Cθ is promoted by diacylglycerol, which is generated from palmitate or by inhibitor κB kinase β, a serine kinase that normally prevents activation of NF-κB(Reference Sinha, Perdomo and Brown23). Oleate has been reported to inhibit the activation of NF-κB in endothelial cells(Reference Massaro, Carluccio and Paolicchi36). Therefore, the protective effect of oleate against palmitate could be due to suppression of the protein kinase Cθ and NF-κB pathways. Thus, oleate protection against palmitate-induced insulin resistance may result from the channelling of diacylglycerol into neutral TAG which does not induce insulin resistance(Reference Sabin, Stewart and Crowne13–Reference Coll, Eyre and Rodriguez-Calvo15, Reference Voshol, Jong and Dahlmans37–Reference Listenberger, Han and Lewis39). It remains to be investigated whether ceramide generation is involved in the protection by oleate against palmitate-induced insulin resistance.
Another detrimental effect of palmitate observed in the present study was the loss of spindle shape of L6 myotubes. Normal cell morphology was restored by co-incubation with 50 μm-oleate, and this was associated with a small increase in membrane integrity. However, the reduction in membrane integrity was much smaller than the reduction in insulin-stimulated glucose uptake caused by palmitate, suggesting that the small loss in cell membrane integrity is not the primary contributor to the palmitate-induced insulin resistance in L6 myotubes. Mitochondrial dysfunction has been implicated in the development of insulin resistance(Reference Kelly, He and Menshikova40), and palmitate diminished the mitochondrial-reducing capacity of L6 cells. Nevertheless, the inability of 50 μm-oleate to restore mitochondrial function while reversing 300 μm-palmitate-induced insulin resistance suggests that improved mitochondrial function is not crucial for the protective effect of oleate against palmitate-induced insulin resistance in muscle. Addition of 150 μm- and 300 μm-oleate partially prevented the palmitate-induced decrease in mitochondrial activity and this protective effect is similar to the addition of increasing concentrations of BSA. This suggests that the protection by the higher concentrations of oleate may partly reflect the increased amount of BSA. There was no effect of palmitate or oleate on apoptosis under the same conditions as assessed by caspase-3 assay on the adherent cells. However, apoptotic cells can lose adherence, so additional measures of cell death are required to exclude an effect on apoptosis.
In summary, the present study has demonstrated a protective effect of the MUFA oleate against insulin resistance induced by the SFA palmitate in L6 muscle cells. This protective effect is associated with the ability of oleate to preserve insulin-stimulated PI3-kinase activity in palmitate-treated cells. The protective effect of oleate has potentially important implications for the balance of dietary monounsaturated and saturated fats in the development of insulin resistance and these data suggest possible benefits of increasing plasma oleate in vivo; an early meta-analysis of dietary fat intake supported the hypothesis that monounsaturated fat may improve diabetic control and this has been substantiated by more recent studies(Reference Ros41–Reference Due, Larsen and Hermansen43). Whether dietary oleate offers a strategy to improve glucose homeostasis in type 2 diabetes mellitus requires further investigation through well-designed, appropriately powered dietary intervention studies.
Acknowledgements
The authors gratefully acknowledge financial support for the present study from Aston University and for D. G. from an Overseas Research Students Awards Scheme (ORSAS) scholarship award.
D. G. undertook all experiments and drafted the manuscript. H. R. G. was principal investigator and supervisor to D. G. and C. J. B. was associate supervisor.
The authors declare that there is no conflict of interest.
